日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Global cancer statistics for children: Two decades of change and projections to 2050

全球儿童癌症统计数据:二十年来的变化及至2050年的预测

Li, Wangzhong; Huang, Shanzhou; Chen, Qiyue; Wang, Ting; Lu, Guanming; Niu, Xing; Song, Qiong; Xu, Yilin; Mo, Ke; Cui, Chunhui; Zhang, Run; Du, Wei; He, Feiying; Shi, Lei; Lin, Yan; Wei, Qiu; Jiang, Li; Chen, Yongsheng; Song, Baiyang; Zhang, Huijuan; Fu, Zhenli; Liao, Wenjing; Sun, Jiancong; Guan, Wenhui; Zhuang, Weitao; Zhong, Nanshan; Zhou, Chengzhi; Liang, Wenhua; Kang, Min; He, Jianxing

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Biochemistry and regulation of histone lysine L-lactylation

组蛋白赖氨酸L-乳酰化的生物化学和调控

Sheng, Xinlei; Lin, Hening; Cole, Philip A; Zhao, Yingming

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial

美国一项多中心、随机、开放标签、非劣效性3期临床试验:质子放射疗法与光子放射疗法治疗口咽癌患者的疗效比较

Frank, Steven J; Busse, Paul M; Lee, J Jack; Rosenthal, David I; Hernandez, Mike; Swanson, David M; Garden, Adam S; Gunn, G Brandon; Patel, Samir H; Snider, James W; Ma, Daniel J; Molitoris, Jason K; Lee, Nancy Y; Parvathaneni, Upendra; McDonald, Mark W; Kalman, Noah S; Lin, Alexander; Mohammed, Nasiruddin; Henson, Christina; Hyde, Christian; Bajaj, Gopal K; Katz, Sanford R; Dagan, Roi; Morrison, William H; Reddy, Jay P; Fuller, C David; Shah, Shalin J; Phan, Jack; Chronowski, Gregory M; Mayo, Lauren; Sturgis, Erich M; Ferrarotto, Renata; Zhu, Xiaorong R; Zhang, Xiaodong; Wang, Li; Hutcheson, Katherine A; El-Naggar, Adel K; Moreno, Amy C; Lee, Anna; Spiotto, Michael T; Gross, Neil D; Lai, Stephen Y; Liao, Jay J; Paly, Jonathan; Liao, Zhongxing; Foote, Robert L

A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机 II 期试验,比较乐伐替尼联合依维莫司与卡博替尼治疗 PD-1 免疫检查点抑制剂治疗后进展的转移性透明细胞肾细胞癌患者的疗效(LenCabo)

Hahn, A W; Chahoud, J; Skelton, W P; Yuan, Y; Zurita-Saavedra, A J; Kovitz, C; Alhalabi, O; Campbell, M T; Jonasch, E; Lin, J K; Desai, M; Santos, M J M N; Hwang, H; Corn, P G; Msaouel, P; Tannir, N M

Photoswitchable isomers to improve grain boundary resilience and perovskite solar cells stability under light cycling

光开关异构体可提高晶界韧性和钙钛矿太阳能电池在光循环下的稳定性

Zhang, Zuhong; Zhu, Rui; Li, Guixiang; Tang, Ying; Wu, Hongzhuo; Zhao, Jinbo; Wu, Jiaxin; Gries, Thomas W; Musiienko, Artem; Zuo, Shengnan; Li, Zhe; He, Bingchen; Su, Zhenhuang; Gao, Xingyu; Zuo, Weiwei; Hou, Bo; Pascual, Jorge; Sapienza, Luca; Wang, Luyao; Deng, Lin-Long; Jia, Yu; Li, Gang; Dyson, Paul J; Nazeeruddin, Mohammad Khaja; Saliba, Michael; Abate, Antonio; Li, Meng

Biomass Demineralization: A Critical Need for Future Biorefineries

生物质脱矿:未来生物炼制厂的关键需求

Santiago-Martínez, Leoncio; Avraamidou, Styliani; Ayala-Cortés, Alejandro; Azike, Ruth; Bakshi, Santanu; Banik, Chumki; Bar-Ziv, Ezra; Canales, Emmanuel; Carlson, Torren; Dumesic, James A; Klinger, Jordan Lee; Lee, Jung Min; Long, Fei; McDonald, Armando G; Mohapatra, Sonali; Ong, Rebecca G; Palomo Gonzalez, Luisiana Fabiola; Pan, Xuejun; Saha, Nepu; Sanchez Castillo, Marco Antonio; Singh, Sandip K; Sorensen, Charles M; Subramaniam, Bala; Tsai, Meng-Lin; Van Lehn, Reid C; Wang, Wenjia; Zavala, Victor M; Huber, George W

In Cellulo Fabrication of Supramolecular Protein Assemblies

超分子蛋白组装体的细胞内制备

Yang, Hongru; Song, Chang Woo; Lu, Jiaxi; Lin, Dingchang

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li